Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: SRS Sequential Sindilimab in Brain Metastasis of NSLSC [Phase 2]
Phase 2 trial update for sequential sintilimab (SRS) in brain metastases from NSCLC.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer [Phase 1, Phase 2]
Clinical trial update for alectinib in RET-rearranged non-small cell lung cancer and RET-mutated thyroid cancer; study terminated with resul…
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer
A terminated clinical trial update evaluating concordance of actionable genomic alterations between tumor tissue and plasma in non-small cel…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung [Phase 2]
Phase 2 trial update evaluating erlotinib in women with previously untreated adenocarcinoma of the lung.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 study evaluating combination of ionizing radiation and ipilimumab in metastatic non-small cell lung cancer has completed with resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: A Study to Evaluate Camrelizumab in Combination With Nb-Paclitaxel in Patients With Advanced or Metastatic NSCLC [Phase 2]
Phase 2 trial evaluating camrelizumab in combination with Nb-paclitaxel for advanced or metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer [Phase 2]
Phase 2 trial evaluating rapid plasma genotyping to initiate erlotinib early in EGFR-mutant non-small cell lung cancer was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 clinical trial evaluating TARCEVA (erlotinib) in combination with chemoradiation for patients with stage IIIA/B non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating adjuvant cisplatin and docetaxel in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase II trial evaluating fruquintinib in combination with gefitinib for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating anlotinib in combination with pembrolizumab for PD-L1–positive, treatment-naïve non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Phase II Study of Pembrolizumab After Curative Intent Treatment for Oligometastatic Non-Small Cell Lung Cancer [Phase 2]
Phase II study evaluating pembrolizumab after curative-intent treatment for oligometastatic non-small cell lung cancer has completed, with r…
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin [Phase 2]
Phase 2 open-label study of ABI-007 (Abraxane) plus carboplatin in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Cancer Associated Thrombosis and Isoquercetin (CATIQ) [Phase 2, Phase 3]
Phase 2/3 clinical trial update for Cancer Associated Thrombosis and Isoquercetin (CATIQ) completed with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC [Phase 3]
Phase 3 trial assessing gefitinib with anlotinib or placebo in newly diagnosed EGFR-mutant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Hypofractionated Accelerated Radiotherapy With Concomitant Chemotherapy for NSCLC [Phase 1, Phase 2]
Clinical trial update for hypofractionated accelerated radiotherapy with concomitant chemotherapy in non-small cell lung cancer (Phase 1/Pha…
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer [Phase 2, Phase 3]
Phase 2/3 study evaluating chemotherapy in combination with autologous cytokine-induced killer cell immunotherapy for non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis [Phase 2]
Phase 2 trial evaluating osimertinib with or without bevacizumab for EGFR-mutant non-small cell lung cancer with leptomeningeal metastasis.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC) [Phase 2]
Phase 2 trial update for BELIEF study combining Bevacizumab and Erlotinib in EGFR-mutant non-small cell lung cancer; results posted after co…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Study of TQ-B3139 in Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib [Phase 2]
A Phase 2 trial update for TQ-B3139 in ALK-positive non-small cell lung cancer patients who were previously treated with crizotinib; current…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 clinical trial comparing TQ-B3139 to crizotinib in first-line ALK-positive non-small cell lung cancer is underway but results are no…
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC [Phase 1]
Phase 1 clinical trial update evaluating TRC105 in combination with paclitaxel/carboplatin and bevacizumab for non-small cell lung cancer ha…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC [Phase 2]
Phase II study evaluating sorafenib in combination with carboplatin and docetaxel as first-line treatment for advanced non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC [Phase 1, Phase 2]
Phase 1/2 trial evaluating apatinib in combination with SHR-1210 for non-small-cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Phase II Study With Cabozantinib in Patients With RET Positive NSCLC [Phase 2]
Phase II study evaluating cabozantinib in RET-positive non-small cell lung cancer is ongoing with an unclear status.